GE HealthCare's Signa Magnus Head-Only MRI Scanner Receives FDA Clearance

Key Insights

• GE HealthCare's Signa Magnus, a head-only MRI scanner, has received 510(k) clearance from the U.S. Food and Drug Administration, facilitating its market entry.
• The Signa Magnus system offers advanced clinical imaging and neuroscience capabilities, potentially improving the detection of various conditions affecting the head.
• Existing facilities can upgrade to the new Signa Magnus system, expanding access to this technology without requiring entirely new installations.

GE HealthCare announced that its Signa Magnus head-only magnetic resonance imaging (MRI) scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance allows GE HealthCare to market and distribute the Signa Magnus system in the United States.

The Signa Magnus is designed to provide advanced clinical imaging and neuroscience capabilities. GE HealthCare suggests that the new system could aid in detecting various conditions affecting the head. The 510(k) clearance pathway is reserved for devices that are substantially equivalent to devices already legally marketed.

According to GE HealthCare, existing facilities can upgrade their current MRI systems to the Signa Magnus, potentially reducing the cost and time associated with adopting the new technology.